About Shandong Sanyuan Biotechnology
Shandong Sanyuan Biotechnology is a company based in Binzhou (China) founded in 2007.. The company has 436 employees as of December 31, 2024. Shandong Sanyuan Biotechnology operates in a competitive market with competitors including Avecia, RiboBio, Liberate Bio, Lerna Biopharma and Shanghai Rui Platinum Biotechnology, among others.
- Headquarter Binzhou, China
- Employees 436 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Shandong Sanyuan Biotechnology Co. Ltd. Class A
-
Annual Revenue
$97.24 M (USD)42.87as on Dec 31, 2024
-
Net Profit
$14.38 M (USD)78.26as on Dec 31, 2024
-
EBITDA
$10.1 M (USD)41721.54as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
436
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shandong Sanyuan Biotechnology
Shandong Sanyuan Biotechnology is a publicly listed company on the SZSE with ticker symbol 301206 in China, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Shandong Sanyuan Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Shandong Sanyuan Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shandong Sanyuan Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shandong Sanyuan Biotechnology Comparisons
Competitors of Shandong Sanyuan Biotechnology
Shandong Sanyuan Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avecia, RiboBio, Liberate Bio, Lerna Biopharma and Shanghai Rui Platinum Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO specializing in oligonucleotide production and complex small molecule synthesis
|
|
| domain | founded_year | HQ Location |
Developer of oligonucleotides
|
|
| domain | founded_year | HQ Location |
Contract manufacturing for tissue-specific nucleic acid therapeutics is provided.
|
|
| domain | founded_year | HQ Location |
Develops nucleic acid therapeutics using chemistry and biological insights for effective treatments.
|
|
| domain | founded_year | HQ Location |
Provider of drug research and development services
|
|
| domain | founded_year | HQ Location |
Nucleic acid development and manufacturing services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shandong Sanyuan Biotechnology
Frequently Asked Questions about Shandong Sanyuan Biotechnology
When was Shandong Sanyuan Biotechnology founded?
Shandong Sanyuan Biotechnology was founded in 2007.
Where is Shandong Sanyuan Biotechnology located?
Shandong Sanyuan Biotechnology is headquartered in Binzhou, China. It is registered at Binzhou, Shandong, China.
Who is the current CEO of Shandong Sanyuan Biotechnology?
Zaijian Nie is the current CEO of Shandong Sanyuan Biotechnology.
How many employees does Shandong Sanyuan Biotechnology have?
As of Dec 31, 2024, the latest employee count at Shandong Sanyuan Biotechnology is 436.
What is the annual revenue of Shandong Sanyuan Biotechnology?
Annual revenue of Shandong Sanyuan Biotechnology is $97.24M as on Dec 31, 2024.
What does Shandong Sanyuan Biotechnology do?
Shandong Sanyuan Biotechnology was founded in 2007 and is based in Binzhou, China. Operations focus on the biotechnology sector, where research and development of new multifunctional sugars are pursued. Services include innovation in sugar-based technologies for various applications. Leadership is provided by CEO Zaijian Nie, with activities centered on advancing multifunctional sugar solutions in the domestic market.
Who are the top competitors of Shandong Sanyuan Biotechnology?
Shandong Sanyuan Biotechnology's top competitors include RiboBio, Liberate Bio and Avecia.
Is Shandong Sanyuan Biotechnology publicly traded?
Yes, Shandong Sanyuan Biotechnology is publicly traded on SZSE under the ticker symbol 301206.
What is Shandong Sanyuan Biotechnology's ticker symbol?
The ticker symbol of Shandong Sanyuan Biotechnology is 301206 on SZSE.